BioCision LLC, a Larkspur, CA-based developer of sample standardization tools and solutions for the life science research and clinical markets, has raised $2.5m in debt and equity financing.
The round was led by BroadOak Capital Partners, with participation from Research Corporation Technologies.
The company intends to use the capital to expand its sales, marketing and product development efforts.
Led by Rolf Ehrhardt, MD, PhD, CEO BioCision provides innovative tools for standardizing sample handling, cryopreservation and storage procedures. The company’s products are used worldwide by researchers in the pharmaceutical, biotechnology, academic and health care industries.